This finding is consistent with previous reports that CDK2 is frequently overexpressed in CC, where it complexes with cyclin E1 to promote p-Rb phosphorylation and E2F1 release, thereby driving cell cycle progression and tumor proliferation [27,28]. Here, E2F1 is linked to neoplasm.